- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01813331
ALERT-HF: Adherence to Guidelines in the Treatment of Patients With Chronic Heart Failure (ALERT-HF)
March 13, 2013 updated by: Oliviero Ugo, Federico II University
ALERT-HF:Adherence to Guidelines in the Treatment of Patients With Chronic Heart Failure
ALERT-HF is an observational study aimed to evaluate the diagnostic criteria adopted and the adherence to the current therapeutic guidelines in a large series of patients affected with chronic heart failure.
Secondary objective is to evaluate the prevalence of chronic heart failure among all the patients referring to the ambulatory cardiologists of the healthcare district.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
660
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Naples, Italy
- ARCA Campania healthcare ambulatories
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Chronic Heart Failure patients older than 65 years, consecutively referred to the A.R.C.A Campania Cardiologists in the pertaining healthcare districts
Description
Inclusion Criteria:
- Diagnosis of Heart Failure
- Signature of informed consent
- Age older than 65 years
Exclusion Criteria:
- indication for cardiac surgery or cardiac surgery by less than 3 months
- age less than 65 years
- inability to perform periodic checks
- presence of malignant neoplasms and other severe diseases.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Chronic Heart Failure Patients
Chronic Heart Failure patients older than 65 years, which accept to participate to the study and give their informed written consent and consecutively refer to the A.R.C.A Campania Cardiologists in the pertaining healthcare districts.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of patients treated with each of the following indicators of adherence to the current therapeutic guidelines:-ACEI -ARB -beta blockers -loop diuretics -aldosterone antagonists -digoxin -anticoagulant therapy - implantation of cardiac devices
Time Frame: first physical examination and clinical evaluation performed during a 3 months period, from November 2012 to January 2013
|
first physical examination and clinical evaluation performed during a 3 months period, from November 2012 to January 2013
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
evaluate the prevalence of chronic heart failure among all the patients referring to the ambulatory cardiologists of the healthcare district
Time Frame: first evaluation
|
first evaluation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2012
Primary Completion (ACTUAL)
January 1, 2013
Study Completion (ACTUAL)
February 1, 2013
Study Registration Dates
First Submitted
March 7, 2013
First Submitted That Met QC Criteria
March 13, 2013
First Posted (ESTIMATE)
March 18, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
March 18, 2013
Last Update Submitted That Met QC Criteria
March 13, 2013
Last Verified
March 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 161/12
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Heart Failure
-
Maastricht University Medical CenterUniversity College Dublin; RWTH Aachen University; Queen's University, BelfastCompletedChronic Heart FailureNetherlands, Germany, Ireland, United Kingdom
-
Wuerzburg University HospitalRecruitingHeart Failure | Chronic Heart Failure | Chronic Heart DiseaseGermany
-
Lithuanian University of Health SciencesCompletedHeart Failure | Chronic Heart Failure | Congestive Heart Failure | Right Ventricular FailureLithuania
-
Zensun Sci. & Tech. Co., Ltd.RecruitingChronic Heart FailureChina
-
Jordan Cardio Vascular Research GroupRecruitingHeart Failure | Chronic Heart Failure | Acute Heart FailureJordan
-
University Hospital, Clermont-FerrandHospices Civils de Lyon; University Hospital, Grenoble; Hôpital de la Croix-Rousse and other collaboratorsRecruitingHeart Failure | Chronic Heart Failure | Acute Heart FailureFrance
-
University of Roma La SapienzaUnknownChronic Heart Failure | Decompensated Heart Failure | Morality
-
University Medicine GreifswaldDeutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)RecruitingChronic Heart FailureGermany
-
Zensun Sci. & Tech. Co., Ltd.Terminated
-
University Hospital, Gentofte, CopenhagenUnknownChronic Heart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IVDenmark